These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans. Qi C; Cai Y; Gunn L; Ding C; Li B; Kloecker G; Qian K; Vasilakos J; Saijo S; Iwakura Y; Yannelli JR; Yan J Blood; 2011 Jun; 117(25):6825-36. PubMed ID: 21531981 [TBL] [Abstract][Full Text] [Related]
5. Suppression of murine tumour growth through CD8 Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313 [TBL] [Abstract][Full Text] [Related]
6. Maturation of dendritic cells by pullulan promotes anti-cancer effect. Zhang W; Yu X; Kwak M; Xu L; Zhang L; Yu Q; Jin JO Oncotarget; 2016 Jul; 7(28):44644-44659. PubMed ID: 27341129 [TBL] [Abstract][Full Text] [Related]
7. Intratumoral CpG-B Promotes Antitumoral Neutrophil, cDC, and T-cell Cooperation without Reprograming Tolerogenic pDC. Humbert M; Guery L; Brighouse D; Lemeille S; Hugues S Cancer Res; 2018 Jun; 78(12):3280-3292. PubMed ID: 29588348 [TBL] [Abstract][Full Text] [Related]
8. Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response. Garris CS; Luke JJ Clin Cancer Res; 2020 Aug; 26(15):3901-3907. PubMed ID: 32332013 [TBL] [Abstract][Full Text] [Related]
9. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses. Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960 [TBL] [Abstract][Full Text] [Related]
10. A lipid-soluble extract of Pinellia pedatisecta Schott enhances antitumor T cell responses by restoring tumor-associated dendritic cell activation and maturation. Wang Y; Huang H; Yao S; Li G; Xu C; Ye Y; Gui S J Ethnopharmacol; 2019 Sep; 241():111980. PubMed ID: 31146000 [TBL] [Abstract][Full Text] [Related]
11. Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity. Wang Z; Xu F; Hu J; Zhang H; Cui L; Lu W; He W; Wang X; Li M; Zhang H; Xiong W; Xie C; Liu Y; Zhou P; Liu J; Huang P; Qin XF; Xia X J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016722 [TBL] [Abstract][Full Text] [Related]
12. Oxidized curdlan activates dendritic cells and enhances antitumor immunity. Bao M; Ehexige E; Xu J; Ganbold T; Han S; Baigude H Carbohydr Polym; 2021 Jul; 264():117988. PubMed ID: 33910726 [TBL] [Abstract][Full Text] [Related]
13. The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity. Martin K; Müller P; Schreiner J; Prince SS; Lardinois D; Heinzelmann-Schwarz VA; Thommen DS; Zippelius A Cancer Immunol Immunother; 2014 Sep; 63(9):925-38. PubMed ID: 24906866 [TBL] [Abstract][Full Text] [Related]
14. Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication. Zom GG; Willems MMJHP; Khan S; van der Sluis TC; Kleinovink JW; Camps MGM; van der Marel GA; Filippov DV; Melief CJM; Ossendorp F J Immunother Cancer; 2018 Dec; 6(1):146. PubMed ID: 30541631 [TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of β-1,3-1,6-glucan derived from black yeast Aureobasidium pullulans in RAW264.7 cells. No H; Kim J; Seo CR; Lee DE; Kim JH; Kuge T; Mori T; Kimoto H; Kim JK Int J Biol Macromol; 2021 Dec; 193(Pt A):592-600. PubMed ID: 34678386 [TBL] [Abstract][Full Text] [Related]
16. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents. Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033 [TBL] [Abstract][Full Text] [Related]
17. β-Glucan enhances cytotoxic T lymphocyte responses by activation of human monocyte-derived dendritic cells via the PI3K/AKT pathway. Ding J; Feng T; Ning Y; Li W; Wu Q; Qian K; Wang Y; Qi C Hum Immunol; 2015 Mar; 76(2-3):146-54. PubMed ID: 25636576 [TBL] [Abstract][Full Text] [Related]
18. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy. da Cunha A; Antoniazi Michelin M; Cândido Murta EF Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825 [TBL] [Abstract][Full Text] [Related]
19. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity. Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406 [TBL] [Abstract][Full Text] [Related]
20. Consumption of β-glucans to spice up T cell treatment of tumors: a review. de Graaff P; Govers C; Wichers HJ; Debets R Expert Opin Biol Ther; 2018 Oct; 18(10):1023-1040. PubMed ID: 30221551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]